Skip to main content

Day: April 8, 2021

Complete 72-Week Results from Phase 3 HOPE Study of Oxbryta® (voxelotor) Tablets Published in The Lancet Haematology Show Significantly Improved Hemoglobin, Hemolysis and Overall Health Status in Sickle Cell Disease Patients

SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced The Lancet Haematology has published the complete analysis of 72-week data from the Phase 3 HOPE Study of Oxbryta® (voxelotor) tablets in patients with sickle cell disease (SCD). The results showed significant and sustained improvement in hemoglobin levels, reduction in hemolysis and improved overall health status in patients treated with Oxbryta. These findings support the long-term use of Oxbryta to reduce hemolytic anemia and hemolysis in SCD, potentially mitigating life-threatening complications of the condition. Oxbryta, a first-in-class oral, once-daily therapy, directly inhibits hemoglobin polymerization, the root cause of the sickling and destruction of red blood cells in SCD. Oxbryta is approved...

Continue reading

Medium Voltage Cables Market to Register 7.4% CAGR till 2028; Rapid Urbanization Worldwide to Strengthen Market Growth: Fortune Business Insights™

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) — The global medium voltage cables market size is projected to reach USD 55.31 billion by 2028, exhibiting a CAGR of 7.4% during the forecast period. Fortune Business Insights™ shares this information in its report, titled “Medium Voltage Cables Market, 2021-2028”. As per the report, the value of the market stood at USD 31.47 billion in 2020. Government Initiatives Promoting Renewable Energy to Enhance Demand In the battle against global warming, governments across the world are launching initiatives to make renewable energy their primary resource for power-related requirements. For instance, Since February 2021, Singapore has initiated its project of building solar farms at Tengeh reservoir. These farms will be floating in the sea as the country lacks real estate. The project is handled...

Continue reading

Neonatal Intensive Care Respiratory Devices Market Size 2021 |To Reach USD 2,431.3 Million in 2028; Rising Respiratory Problems in Infants to Boost Growth, says Fortune Business Insights™

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) — The global “neonatal intensive care respiratory devices market is set to gain impetus from the increasing cases of preterm births. As per the World Health Organization (WHO), every year, around 15 million babies are born worldwide. Among them, 11% are preterm births. This information is given by Fortune Business Insights™ in a new report, titled, “Neonatal Intensive Care Respiratory Devices Market, 2021-2028.” The report further states that the neonatal intensive care respiratory devices market size is projected to grow from USD 1,636.2 million in 2021 to USD 2,431.3 million in 2028 at a CAGR of 5.8% in the forecast period. The COVID-19 pandemic has had a staggering impact on the market. It stood at USD 1,546.9 million in 2020. Neonatal intensive care respiratory devices exhibited normal...

Continue reading

Dentures Market to Increase at a CAGR of 6.4% and Hit USD 3.82 Billion by 2027; Will Gain Momentum from Increasing Number of Dental Procedures Worldwide: Fortune Business Insights™

Pune, India, April 08, 2021 (GLOBE NEWSWIRE) — The global Dentures Market is expected to rise remarkably on account of the increasing prevalence of dental issues and periodontal diseases world wide. Dentures are customized artificial teeth gums that are replaced with lost or removed teeth. They are shaped accordingly as per the oral structure of the patient. As per a recently published report by Fortune Business Insights™ titled, “Dentures Market Size, Share & Industry Analysis, By Type (Complete and Partial), By Usage (Removable and Fixed), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2020-2027,”the market stood at USD 2.33 billion in 2019 and is anticipated to reach USD 3.82 billion by 2027 by exhibiting a CAGR of 6.4% between 2020 and 2027. Major Dentures Market Key...

Continue reading

International Journal of Pharmaceutics Publishes Study on the NanoZolid® Technology for Local Release of Biomolecules

UPPSALA, SWEDEN – LIDDS AB (publ) announced today that the journal International Journal of Pharmaceutics has accepted a biomolecule study from LIDDS for publication. The investigation has been performed in collaboration with the Karolinska Institute in Huddinge, Sweden and Truly labs in Lund, Sweden. The study confirms that proteins are released from NanoZolid® depots with maintained bio-functionality, illustrated by protein targeting to tumor cell receptors. The investigation was performed with fluorescence-imaging.                                                     The NanoZolid® technology has during the last years been shown to enable a controlled release of a wide range of drugs following a single injection, resulting in stable and pharmacologically validated effects over a desired time period. In this study, a fluorescence-labelled...

Continue reading

Cegedim e-business poursuit son accélération sur le segment mid market et ambitionne de doubler le nombre de nouveaux clients en 2021

Boulogne-Billancourt, le 8 avril 2021 – Acteur majeur de la digitalisation et de l’automatisation des process BtoB en Europe, Cegedim e-business relève le défi des petites et moyennes entreprises en les soutenant dans leurs processus métiers et en leur proposant des solutions adaptées, disponibles et opérationnelles rapidement. Pour preuve, le lancement il y a un an d’une version simplifiée de sa solution de dématérialisation SY by Cegedim. Spécifiquement packagée pour les PME et ETI afin de faciliter la gestion de leurs factures, cette offre a déjà été intégrée par plus de 50 entreprises de secteurs différents. Vanina Chevallier, Responsable de marché chez Cegedim e-business indique : « Le recours obligatoire à la facture électronique pour toutes les entreprises dès 2023 et le contexte sanitaire qui bouscule l’organisation au travail,...

Continue reading

Capgemini Press Release// Capgemini brings together its engineering and R&D expertise with the launch of new brand: ‘Capgemini Engineering’

Good morning, Please find below the press release issued today. Best regards, Florence LièvreGlobal PR Manager | Group Marketing & Communications Capgemini Group | ParisTel.: +33 1 47 54 50 71Email : florence.lievre@capgemini.com_____________________ Press contact:Sam ConnattyTel: +44 (0) 370 904 3601Email: sam.connatty@capgemini.comm Capgemini brings together its engineering and R&D expertise with the launch of new brand: ‘Capgemini Engineering’ Combined under one brand is a unique set of strengths from across the Group: the world leading engineering and R&D services of Altran and Capgemini’s digital manufacturing expertise Paris, April 08, Capgemini unveiled today ‘Capgemini Engineering’, which consolidates a unique set of market leading capabilities in engineering and R&D. Along with the Group’s deep industry expertise...

Continue reading

Communiqué de presse Capgemini// Capgemini rassemble ses expertises en ingénierie et en R&D au sein d’une nouvelle marque : “Capgemini Engineering”

Bonjour, Vous trouverez ci-après le communiqué de presse diffusé ce jour. Bien cordialement, Florence LièvreGlobal PR Manager | Group Marketing & Communications Capgemini Group | ParisTel.: +33 1 47 54 50 71Email : florence.lievre@capgemini.com_____________________ Contact presse :Florence LièvreTél. : 01 47 54 50 71E-mail : florence.lievre@capgemini.com Capgemini rassemble ses expertises en ingénierie et en R&D au sein d’une nouvelle marque : “Capgemini Engineering” Réunies sous une seule et même marque, une combinaison unique de compétences issues de l’ensemble du Groupe : les services d’ingénierie et de R&D d’Altran, leaders dans leur domaine, alliés à la forte expertise de Capgemini en matière de ‘digital manufacturing’. Paris, le 8 avril 2021 – Capgemini dévoile ‘Capgemini Engineering’ qui regroupe...

Continue reading

Nexity: Nexity enters into exclusive negotiation with AG2R LA MONDIALE for the disposal of a majority stake in Ægide-Domitys and a strategic partnership for the development of senior residences.

NEXITY ENTERS INTO EXCLUSIVE NEGOTIATIONS WITH AG2R LA MONDIALE FOR THE DISPOSAL OF A MAJORITY STAKE IN ÆGIDE-DOMITYS AND A STRATEGIC PARTNERSHIP FOR THE DEVELOPMENT OF SENIOR RESIDENCES.STRENGTHENING OF THE RELATIONSHIP BETWEEN AG2R LA MONDIALE AND NEXITY. Paris, April 8, 2021, 8.30 am CEST Nexity and AG2R LA MONDIALE signed yesterday, April 7, 2021, agreements allowing them to enter into exclusive negotiations for the disposal of control of the Ægide-Domitys group. The founders, around Jean-Marie Fournet (JMF Conseil) are committed in this transaction. Nexity would sell 45% of the capital and retain an 18% stake in Ægide-Domitys, remaining a significant minority shareholder for the long term. At the closing, Ægide-Domitys’ capital would be distributed as follows:– AG2R LA MONDIALE 67%;– Nexity 18%;– JMF Conseil 15%. The...

Continue reading

Nexity : Nexity entre en négociations exclusives avec AG2R LA MONDIALE pour la cession de la majorité du capital d’Aegide-Domitys et la conclusion d’un partenariat stratégique en matière de promotion de résidences services seniors (RSS).

NEXITY ENTRE EN NÉGOCIATIONS EXCLUSIVES AVEC AG2R LA MONDIALE POUR LA CESSION DE LA MAJORITÉ DU CAPITAL D’AEGIDE-DOMITYS ET LA CONCLUSION D’UN PARTENARIAT STRATEGIQUE EN MATIERE DE PROMOTION DE RESIDENCES SERVICES SENIORS (RSS).RENFORCEMENT DES LIENS ENTRE AG2R LA MONDIALE ET NEXITY. Paris, 8 avril 2021, 8h30 Nexity et AG2R LA MONDIALE ont signé hier, 7 avril 2021, des accords leur permettant d’entrer en négociations exclusives pour la cession du contrôle du groupe Aegide-Domitys. Les fondateurs, autour de Jean-Marie Fournet (JMF Conseil) sont également parties prenantes à cette transaction. Nexity céderait 45% du capital et conserverait une participation de 18% dans Aegide-Domitys. Elle entend rester un actionnaire minoritaire significatif sur un horizon de temps long. Á l’issue de la transaction, le capital d’Aegide-Domitys serait réparti...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.